Empowering patients with biological data to predict and prevent asthma attacks
Patented sensor and device measures airway inflammation in breath via fractional exhaled nitric oxide (FeNO). We use it to biologically
determine risk of attack, adherence, efficacy of medication, and exposure to environmental triggers.
https://www.mybiometry.com/